We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Wide-Range, Automated Dabigatran Assay Launched

By LabMedica International staff writers
Posted on 18 Nov 2015
A new assay kit for dabigatran (Pradaxa) measurement in blood plasma provides automation, higher specificity, and broader working range (currently for research use only).

Diagnostica Stago, Inc., the US subsidiary of hemostasis leader Diagnostica Stago, S.A.S. More...
France (Asnières sur Seine, France), expands its offering for direct measurement of oral anticoagulants (DOACs) with the launch of STA-ECA-II—a next-generation ecarin-based chromogenic assay for dabigatran (Pradaxa). With this addition, Stago offers the only complete portfolio of assays for measurement of DOACs. Automated with barcoded loading on Stago’s high-throughput analyzers, STA-ECA-II enables laboratories an efficient and standardized approach to measure dabigatran in plasma samples.

STA-ECA-II is a highly-specific tool for directly measuring dabigatran (Pradaxa) concentration in plasma and is insensitive to lupus anticoagulants and heparin along with coagulation factor and fibrinogen levels. With a wide working range of 15–460 ng/mL and 28-day stability at 2–8 °C, the kit is flexible for a variety of sample testing requirements.

Compared to liquid chromatography-mass spectrometry (LC-MS)-based methods, STA-ECA-II demonstrates excellent correlation for measurement of total dabigatran concentrations. It provides confidence in results across the entire measurement range, with an advantage over other methods, especially for samples with low concentrations.

The STA-ECA-II kit (catalog number 01108), along with the STA-Dabigatran Calibrator (catalog number 01109) and STA-Dabigatran Control (catalog number 01110) products are labeled for research-use-only in the United States and Canada, and are not for use in diagnostic procedures.

Related Links:

Diagnostica Stago 
Diagnostica Stago, US 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: WashU Medicine researchers found that dozens of blood proteins shift during Alzheimer’s treatment and may help monitor the effects of the medication. (Image Credit: Matt Miller/WashU Medicine)

Blood Biomarker Patterns Could Support Monitoring of Anti-Amyloid Treatment

Patients with early-stage Alzheimer’s disease may receive anti-amyloid therapy to clear amyloid protein deposits from the brain. These treatments can slow disease progression, but they do not cure the... Read more

Molecular Diagnostics

view channel
Image: University of Florida scientists Hugh Fan, Ph.D., and John Lednicky, Ph.D., led the development of a cost-effective, accurate handheld device capable of simultaneously testing for seven different mosquito-borne viruses. (Image Credit: UF Health photo by Hannah Clark)

Portable Test Differentiates Seven Mosquito-Borne Viruses at Point of Care

Mosquito-borne viral illnesses can present with overlapping symptoms such as fever, joint pain, fatigue, and rash, making them difficult to distinguish without laboratory testing. In these settings, clinicians... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.